You have successfully sign out
Loading...
Cardio Diagnostics Holdings, Inc.
CDIOW
Company Description
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Â
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
0.02USD
0.00Â ( 13.92%)
Pre-market 0.02$0.00 (6.79%)Market Closed (as of Oct 02, 20:00 EDT)
Relative Strenght
54
Volume Buzz
-26%
Earning Acce
No
Dist 52w H.
0%
